Listing 1 - 4 of 4 |
Sort by
|
Choose an application
Antineoplastic agents. --- Anticancer agents --- Antineoplastic drugs --- Antineoplastics --- Antitumor agents --- Antitumor drugs --- Cytotoxic drugs --- Inhibitors, Neoplasm --- Neoplasm inhibitors --- Drugs --- Cancer --- Chemotherapy
Choose an application
This book, written by respected experts, discusses in detail the latest developments in targeted therapy for hematologic malignancies using small molecules. It covers a wide range of small molecules including tyrosine kinase inhibitors, immunomodulatory drugs, the IDH-2 inhibitor enasidenib, the BCL-2 inhibitor venetoclax, and the proteasome inhibitor carfilzomib. For each molecule, aspects such as the chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed. Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of precision cancer therapy is now growing rapidly, and the advances being made will mean significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. An accompanying volume addresses the use of small molecules in oncology, and the two volumes together represent the third edition of the book originally published under the same title. .
Antineoplastic agents. --- Hematology. --- Haematology --- Internal medicine --- Blood --- Anticancer agents --- Antineoplastic drugs --- Antineoplastics --- Antitumor agents --- Antitumor drugs --- Cytotoxic drugs --- Inhibitors, Neoplasm --- Neoplasm inhibitors --- Drugs --- Cancer --- Diseases --- Chemotherapy --- Oncology . --- Oncology. --- Tumors
Choose an application
Cancer Reports is a broad scope journal dedicated to publishing data-driven, scientifically valid findings at every step in basic, translational, clinical and interdisciplinary research in cancer development, treatment, care and outcome including: Early stage and incremental findings - Replication studies - Negative findings.
Oncology. Neoplasms --- cancer biology --- clinical oncology --- bioinformatics --- psycho-oncology --- cancer immunology --- anticancer agents --- Cancer. --- Cancer --- Neoplasms. --- Diagnosis. --- Treatment. --- Cancer therapy --- Cancer treatment --- Cancers --- Carcinoma --- Malignancy (Cancer) --- Malignant tumors --- Tumors --- Benign Neoplasms --- Malignancy --- Malignant Neoplasms --- Neoplasia --- Neoplasm --- Neoplasms, Benign --- Benign Neoplasm --- Malignancies --- Malignant Neoplasm --- Neoplasias --- Neoplasm, Benign --- Neoplasm, Malignant --- Neoplasms, Malignant --- Tumor --- Medical Oncology --- Therapy
Choose an application
Antineoplastic agents. --- Anticancer agents --- Antineoplastic drugs --- Antineoplastics --- Antitumor agents --- Antitumor drugs --- Cytotoxic drugs --- Inhibitors, Neoplasm --- Neoplasm inhibitors --- Drugs --- Cancer --- Chemotherapy --- Neoplasms --- Antineoplastic Agents --- Biological Products --- drug therapy --- therapeutic use --- therapy --- E-books --- Biological products --- Chemotherapy. --- Immunotherapy. --- Therapeutic use --- Biological response modifiers. --- Biological response modulators --- Biomodulators --- BRMs (Biochemistry) --- Immunomodulators --- Immunoregulators --- Modifiers, Biological response --- Modulators, Biological response --- Biomolecules --- Cellular control mechanisms --- Immunopharmacology --- Immune response --- Antineoplastic agents --- Immunotherapy --- Regulation --- Immunological aspects --- Treatment
Listing 1 - 4 of 4 |
Sort by
|